Patent US3039922A successfully refreshed from Google Patents.
US3039922A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Method of administering tablets having decongestant and anti-histaminic activity
Assignee: Carter Products Inc
•
Filing: 1959-08-17
•
Granted: 1962-06-19
•
Expires: 1979-08-17
Abstract
No abstract record available.
Inventors
- 👤 Frank M Berger
- 👤 Wielich Kurt Hans
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-24 05:24
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/0012; A61K9/0053; A61K9/006; A61K31/00; A61K31/33; A61K31/395; A61K31/435; A61K31/44
Claims Analysis
Total Claims: 2
Claim 1
Independent Claim
124 words
THE METHOD OF ADMINISTERING A DECONGESTANT AND AN ANTI-HISTAMINE AGENT TO A WARM BLOODED ANIMAL OF ABSORPTION FROM ITS ORAL CAVITY, COMPRISING APPLYING TO THE ORAL MUCOSA AND SAID ANIMAL A TABLET COMPRISING A PHARMACOLOGICALLY ACCEPTABLE SALT OF PHENYLEPHRINE CAPABLE OF BEING ABSORBED THROUGH THE ORAL MUCOSA OF SAID ANIMAL TO EXERT DECONGESTANT ACTIVITY, A PHARMACOLOGICALLY ACCEPTABLE SALT OF CHLORPHENIRAMINE CAPALE OF BEING ABSORBED THROUHG THE ORAL MUCOSA OF SAID ANIMAL TO EXERT ANTI-HISTAMINIC ACTIVITY, A WATER SOLUBLE FILLER, A DISINTERGRANT, A WATER INSOLUBLE INERT FILLER, A LUBRICANT AND A BINDING AGENT AND, PERMITTING THE TABLET TO REMAIN IN CONTACT WITH THE ORAL MUCOSA FOR A SUFFICIENT PERIOD OF TIME WHEREBY THE PHENYLEPHRINE SALT AND THE CHLORPHENIRAMINE SALT ARE ABSORBED FROM THE ORAL CAVITY.
Claim 2
Independent Claim
124 words
THE METHOD OF ADMINISTERING A DECONGESTANT AND AN ANTI-HISTAMINE AGENT TO A WARM BLOODED ANIMAL OF ABSORPTION FROM ITS ORAL CAVITY, COMPRISING APPLYING TO THE ORAL MUCOSA AND SAID ANIMAL A TABLET COMPRISING A PHARMACOLOGICALLY ACCEPTABLE SALT OF PHENYLEPHRINE CAPABLE OF BEING ABSORBED THROUGH THE ORAL MUCOSA OF SAID ANIMAL TO EXERT DECONGESTANT ACTIVITY, A PHARMACOLOGICALLY ACCEPTABLE SALT OF CHLORPHENIRAMINE CAPALE OF BEING ABSORBED THROUHG THE ORAL MUCOSA OF SAID ANIMAL TO EXERT ANTI-HISTAMINIC ACTIVITY, A WATER SOLUBLE FILLER, A DISINTERGRANT, A WATER INSOLUBLE INERT FILLER, A LUBRICANT AND A BINDING AGENT AND, PERMITTING THE TABLET TO REMAIN IN CONTACT WITH THE ORAL MUCOSA FOR A SUFFICIENT PERIOD OF TIME WHEREBY THE PHENYLEPHRINE SALT AND THE CHLORPHENIRAMINE SALT ARE ABSORBED FROM THE ORAL CAVITY.
References Cited (Backward Citations)
No citation records indexed.
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1965-06-18 | 1965-12-18 | 1966-06-19 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1969-06-18 | 1969-12-18 | 1970-06-19 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1973-06-18 | 1973-12-18 | 1974-06-19 | $7700.00 | Window Closed / Lapsed |